# Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid

> **NCT01532895** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 400 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Hydromorphone HCI OROS

## Key facts

- **NCT ID:** NCT01532895
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2014-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532895, "Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01532895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*